Physician profile
Gary Farley
NPI 1699715698
$3,215.96
in general payments reported to CMS, 2019-2025
23 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $193 · 2021: $418 · 2022: $917 · 2023: $752 · 2024: $461 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251 · Education: $97.99 · Entertainment: $21.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.32 |
| Education | $97.99 |
| Entertainment | $21.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $938.89 | 2022-2024 | Acthar |
| Johnson & Johnson Vision Care, INC. | $410.34 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $337.40 | 2022-2025 | Infuse, Scoutpro Osmolarity System, Miebo |
| Notal Vision, INC. | $268.20 | 2022 | |
| Alcon Vision LLC | $225.11 | 2019-2025 | Total30, Precision7 |
| Coopervision INC. | $204.89 | 2019-2025 | Biofinity Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $155.50 | 2019-2021 | |
| Oyster Point Pharma, INC. | $103.11 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $102.86 | 2021-2023 | |
| Biotissue Holdings INC. | $96.36 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $66.88 | 2019-2021 | |
| Allergan, INC. | $48.49 | 2021 | |
| Maculogix, INC. | $47.39 | 2019 | |
| Optos, INC. | $37.86 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Horizon Therapeutics Plc | $32.81 | 2021-2023 | Tepezza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $31.67 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $25.73 | 2024 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $17.19 | 2024 | Iyuzeh |
| Alcon Research LLC | $15.47 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $10.99 | 2019 | |
| Oasis Medical, INC. | $10.80 | 2021 | |
| Abb Con-Cise Optical Group LLC | $8.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Farley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.